Viewpoint explores effects of GLP-1–based antiobesity medications on skeletal muscle mass in obesity, highlighting implications for weight regain.
This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity.
No takes yet. Share an insight, caveat, or question.
Conte et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: